Journal of Pediatric Health Care
Volume 18, Issue 5 , Pages 224-227 , September 2004

Rate of palivizumab administration in accordance with current recommendations among hospitalized children

  • James A. Moynihan, MS, DO, FAAP

      Affiliations

    • Corresponding Author InformationReprint requests: James A. Moynihan, DO, Loma Linda University Medical Center and Children's Hospital, Department of Emergency Medicine, 11234 Anderson St, Room A108, Loma Linda, CA 92354-2804
    • James A. Moynihan is the Assistant Medical Director, Department of Emergency Medicine at Loma Linda University Medical Center & Children's Hospital, Department of Pediatric Emergency Medicine, Loma Linda, Calif.
    • ,
  • Tommy Y. Kim, MD, FAAP

      Affiliations

    • Tommy Y. Kim is a Senior Fellow, Department of Emergency Medicine at Loma Linda University Medical Center & Children's Hospital, Loma Linda, Calif.
    • ,
  • Tammy Young, MSN, RN, FNP

      Affiliations

    • Tammy Young is a doctoral student (DrPH) at Loma Linda University, School of Public Health, Loma Linda, Calif. She is a staff nurse at Loma Linda University Medical Center & Children's Hospital, Pediatric Emergency Department, Loma Linda, Calif, and Chief Flight Nurse for JetWest International Medical Transportation, Van Nuys, Calif.
    • ,
  • Paul A. Checchia, MD, FAAP

      Affiliations

    • Paul A. Checchia is Director, Divisions of Critical Care Medicine and Cardiology, Washington University School of Medicine, St. Louis Children's Hospital, St. Louis, Mo.

References 

    References
  1. Alessandrini EA, Shaw KN, Bilker WB, Schwarz DF, Bell LM. Effects of medicaid managed care on quality: Childhood immunizations. Pediatrics. 2001;107:1335–1342
  2. Buckingham SC, Quasney MW, Bush AJ, DeVincenzo JT. Respiratory syncytial virus infections in the pediatric intensive care unit: Clinical characteristics and risk factors for adverse outcomes. Pediatric Critical Care Medicine. 2001;2:318–323
  3. Centers for Disease Control and Prevention . Respiratory syncytial virus activity—United States, 1999-2000 season. Journal of the American Medical Association. 2001;285:287–288
  4. Committee on Infectious Diseases and Committee on Fetus and Newborn . Prevention of respiratory syncytial virus infections: Indications for the use of palivizumab and update on the use of RSV-IGIV. Pediatrics. 1998;102:1211–1216
  5. Deming LM. Case management for pediatric respiratory syncytial virus outcomes. The Case Manager. 2002;13:72–74
  6. IMpact-RSV Study Group . Palivizumab, a humanized respiratory syncytial virus monoclonal antibody, reduces hospitalization from respiratory syncytial virus infection in high-risk infants. Pediatrics. 1998;102:531–537
  7. Leader S, Kohlhase K. RSV-coded pediatric hospitalizations and associated charges, 1997-1999. Pediatric Infectious Disease Journal. 2002;21:629–632
  8. Lieu TA, Smith MD. Health insurance and preventive care sources of children at public immunization clinics. Pediatrics. 1994;93:373–378
  9. Lindeke LL, Krajicek M, Patterson DL. PNP roles and interventions with children with special needs and their families. Journal of Pediatric Health Care. 2001;15:138–143
  10. McManus MA, Newacheck P. Health insurance differentials among minority children with chronic conditions and the role of federal agencies and private foundations in improving financial access. Pediatrics. 1993;91:1040–1047
  11. Meissner HC, Welliver RC, Chartrand SA, Law BJ, Weisman LE, Dorkin HL, et al.  Immunoprophylaxis with palivizumab, a humanized respiratory syncytial virus monoclonal antibody, for prevention of respiratory syncytial virus infection in high-risk infants: A consensus opinion. Pediatric Infectious Disease Journal. 1999;18:223–231
  12. Newacheck PW, Halfon N. Access to ambulatory care services for economically disadvantaged children. Pediatrics. 1986;78:813–819
  13. Newacheck PW, Stoddard JJ, McManus M. Ethnocultural variations in the prevalence and impact of childhood chronic conditions. Pediatrics. 1993;91:1031–1039
  14. Shay DK, Holman RC, Newman RD, Liu LL, Stout JW, Anderson LJ. Bronchiolitis-associated hospitalizations among U.S. children, 1980-1996. Journal of the American Medical Association. 1999;282:1440–1446
  15. Thompson WW, Shay DK, Weintraub E, Brammer L, Cox N, Anderson L, et al.  Mortality associated with influenza and respiratory syncytial virus in the United States. Journal of the American Medical Association. 2003;289:2499–2503

PII: S0891-5245(04)00064-1

doi: 10.1016/j.pedhc.2004.02.006

Journal of Pediatric Health Care
Volume 18, Issue 5 , Pages 224-227 , September 2004

Article Tools